In the US, DiviTum® TKa for early breast cancer monitoring is offered as an LDT. The test has not been cleared or approved by the FDA for use in monitoring early breast cancer.
In Europe, the test is CE-IVD for use in metastatic breast cancer. If you want to know more click here
